Exagen announces new rheumatoid arthritis scientific advisory board

San diego, march 16, 2022 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, announced today the formation of its new scientific advisory board (sab) with appointment of seven doctors and rheumatology experts. the sab includes stanley cohen, md; andrew concoff, md, facr, caqsm; kevin deane, md, phd; paul j. demarco, md; harris perlman, phd; eric ruderman, md; and marina sirota, phd.
XGN Ratings Summary
XGN Quant Ranking